I received last week a great study published in January/2017 by KPMG entitled “Pharma Outlook 2030: From evolution to revolution”.
New legislation in Brazil aims to create a balance between using genetic resources for scientific advancement and spreading the benefits
WHO WILL YOU MEET AT BIO LATIN AMERICA? Hundreds of decision-makers from the top multinational, U.S. and Latin American
Biominas Brasil and Thomson Reuters today announced a strategic partnership that will combine Thomson Reuters’ expertise in market data with
Get deeper insight into the Latin American market Expert led panel discussions will increase your understanding of, and interaction with,
By Laura Lunardi, Technical Analyst of Biominas Brasil and Thiago Bajur, Executive Manager of Arkmeds. Few people know clinical engineering and
Presenting is the perfect chance to increase your visibility and attract more partners at the 2016 BIO Latin America Conference.
Market entry. Trade agreements. The regulatory and commercial environment. Innovation. Tactical strategies. The road map for doing business in Latin
Exciting things ahead Meet the advisory committee for the BIO Latin America 2016 Conference! We are working hard on
PSI Immunology is a Platform of Immunological Solutions to develop products and processes to replace or reduce the use of
